Cargando…
Synthetic GM1 improves motor and memory dysfunctions in mice with monoallelic or biallelic disruption of GM3 synthase
This study attempts to answer the question of whether mice with biallelic and monoallelic disruption of the St3gal5 (GM3 synthase) gene might benefit from GM1 replacement therapy. The GM3 produced by this sialyltransferase gives rise to downstream GD3 and the ganglio‐series of gangliosides. The latt...
Autores principales: | Chowdhury, Suman, Kumar, Ranjeet, Zepeda, Evelyn, DeFrees, Shawn, Ledeen, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476560/ https://www.ncbi.nlm.nih.gov/pubmed/37401916 http://dx.doi.org/10.1002/2211-5463.13669 |
Ejemplares similares
-
The Key Role of GM1 Ganglioside in Parkinson’s Disease
por: Chowdhury, Suman, et al.
Publicado: (2022) -
Age-Related Decline in Gangliosides GM1 and GD1a in Non-CNS Tissues of Normal Mice: Implications for Peripheral Symptoms of Parkinson’s Disease
por: Chowdhury, Suman, et al.
Publicado: (2023) -
Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson’s Disease?
por: Alselehdar, Samar K., et al.
Publicado: (2021) -
Systemic deficiency of GM1 ganglioside in Parkinson’s disease tissues and its relation to the disease etiology
por: Ledeen, Robert, et al.
Publicado: (2022) -
GM animals - another GM crops?
por: Bruce, Ann
Publicado: (2007)